Clinical trial
Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome
NCT07568860 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sleep-Driven Adaptive Neuromodulation in Lennox-Gastaut Syndrome
- Lead sponsor
- University of Minnesota
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- December 30, 2031
- Enrollment
- 4 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy, lennox gastaut syndrome (lgs)